Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | GPR183 | P32249 | 5/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | GRM5 | P41594 | 13/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12307491 | 0.86 | HDAC6 (0.64) | HDAC6GRM5 | |
| SCHEMBL12307494 | 0.81 | GRM5 (0.58) | HDAC6GRM5 | |
| SCHEMBL12307409 | 0.81 | GRM5 (0.60) | HDAC6GRM5 | |
| SCHEMBL12307490 | 0.81 | GRM5 (0.56) | HDAC6GRM5 | |
| SCHEMBL12307493 | 0.78 | HTT (0.49) | HDAC6GRM5 | |
| SCHEMBL12307496 | 0.78 | GRM5 (0.47) | HDAC6GRM5 | |
| SCHEMBL16309447 | 0.77 | GRM5 (0.50) | HDAC6GPR183GRM5 | |
| SCHEMBL12307495 | 0.74 | GRM5 (0.44) | HDAC6GRM5 | |
| SCHEMBL12532922 | 0.74 | GRM5 (0.44) | HDAC6GRM5 | |
| SCHEMBL12307488 | 0.73 | PIK3CG (0.45) | HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110230472-A1 | RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110230472-A1 | RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230472-A1 | RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY | PIK3R5, PIK3R4, PIK3R1 | HDAC6 1429/4885GPR183 1511/4885KCNH2 3837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.